What to do with acute atrial fibrillation? - Editorial

American Heart Journal

Volumn 137, Issue 4 I, 1999, Pages 601-602

  Califf, R M ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; IBUTILIDE; SODIUM CHANNEL;

CARDIOVERSION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDITORIAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; STROKE;

EID: 0032912839     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70211-5     Document Type: Editorial

References (1)

1. Abi-Mansour P, McCowan R, Henthorn R, Dunn G, Perry K, and the study investigators. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Am Heart J 1998;136:632-42.